global trials on for hepatitis--B indication : British multinational Glaxo has registered its potential blockbuster anti-AIDS drug, lamivudine (also known as 3-TC), with the Drugs Controller
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/glaxo-bring-anti-hiv-drug
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-express-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health